Shares of Tempus AI (NASDAQ:TEM) dropped 19% Tuesday, the day after the AI-focused healthcare company released a Q4 earnings ...

We recently published a list of 10 AI Stocks on Analysts’ Radar As AI Spending Grows. In this article, we are going to take a ...

At this time, I would like to welcome everyone to the Tempus fourth-quarter 2024 financial results conference call. Thank you, Jason. Good afternoon and welcome to Tempus fourth-quarter 2024 ...

Tempus AI (TEM) reports Q4 earnings Monday, expected loss of 20 cents/share, $203.12M in revenues. Stock up 98.80% YTD.

Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...

EST Tempus AI (TEM) down 7% at $64.83 after Q4 earnings miss and guidanceDiscover the Best Stocks and Maximize Your Portfolio: See what ...

Despite filing a fourth-quarter and yearend 2024 earnings report that the CEO described as "fantastic" yesterday afternoon, ...

JPMorgan downgraded Tempus AI (TEM) to Neutral from Overweight with a price target of $55, up from $50. The company reported Q4 results in-line ...

Tempus AI Inc (TEM) reports impressive revenue growth, strategic acquisitions, and extended partnerships, setting the stage for a promising 2025.

Would you like to be notified of the latest news and updates on the stock market?

Tempus posted a fourth-quarter adjusted net loss of $0.18 per share, $0.02 more per share than estimates by analysts surveyed by Visible Alpha. Revenue jumped 36% year-over-year to $200.7 million, but ...

The health care technology company posted revenue of $200.7 million in the period. For the year, the company reported a loss of $705.8 million, or $6.23 per share. Revenue was reported as $693.4 ...